SEC Form 4 · accession 0001493152-18-010232
Provention Bio, Inc. · PRVB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eleanor Ramos
Officer — Chief Medical Officer & COO
Period of report
Jul 19, 2018
Accepted (ET)
Jul 19, 2018 · 5:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001695357
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share | Jul 19, 2018 | P | 60,000 | $4.00 | A | 60,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The securities were purchased pursuant to an underwritten public offering by the Issuer. The offering closed on July 19, 2018.